Related Experiment Video

Updated: Oct 14, 2025

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
06:39

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation

Published on: August 19, 2020

5.8K

Crescentic Glomerulonephritis: Pathogenesis and Therapeutic Potential of Human Amniotic Stem Cells

Ahmed Al Mushafi1, Joshua D Ooi1, Dragana Odobasic1

  • 1Department of Medicine, Monash Medical Centre, Centre for Inflammatory Diseases, Monash University, Clayton, VIC, Australia.

Frontiers in Physiology
|November 1, 2021
PubMed

Insights

New research explores human amniotic epithelial cells (hAECs) as a safer alternative therapy for crescentic glomerulonephritis (GN), a severe kidney disease. These stem cells show promise in treating GN with fewer side effects than current treatments.

Area of Science:

  • Nephrology
  • Immunology
  • Regenerative Medicine

Background:

  • Chronic kidney disease (CKD) is a major global health concern.
  • Glomerulonephritis (GN) is a leading cause of CKD, with crescentic GN being the most severe form.
  • Current treatments for crescentic GN involve broad immunosuppressants with significant toxicity and side effects.

Purpose of the Study:

  • To review the immunopathogenesis of crescentic GN.
  • To highlight the limitations of existing therapies for crescentic GN.
  • To explore the potential of human amniotic epithelial cells (hAECs) as a novel therapeutic strategy.

Main Methods:

  • Review of existing literature on crescentic GN.
  • Analysis of the immunopathogenesis of GN.
  • Evaluation of the therapeutic properties of hAECs.

Main Results:

  • Crescentic GN is characterized by rapid glomerular damage.
  • Current immunosuppressive therapies are associated with severe adverse events.
  • hAECs possess unique immunosuppressive properties and a favorable safety profile.

Conclusions:

  • There is a critical need for safer and more effective treatments for crescentic GN.
  • hAECs represent a promising, novel therapeutic option for crescentic GN.
  • hAECs offer a potentially harmless alternative to current treatments for this severe kidney disease.

Keywords:
chronic kidney diseasecrescentic glomerulonephritishuman amniotic stem cellsimmunityinflammation

More Related Videos

Isolation, Cryopreservation and Culture of Human Amnion Epithelial Cells for Clinical Applications05:31

Isolation, Cryopreservation and Culture of Human Amnion Epithelial Cells for Clinical Applications

Published on: December 21, 2014

14.1K
A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells09:05

A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells

Published on: August 7, 2017

7.0K

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
96
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.1K